{"database": "openregs", "table": "documents", "rows": [["FDA-2005-D-0140-0009", "FDA", "FDA-2005-D-0140", "Reference 9 - Federal Register, August 24, 2007 (72 FR 48765), Current Good Manufacturing Practice for Blood and Blood Components; Notification of Consignees and Transfussion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting Hepatitis C Virus Infection (\"Lookback\"); Final Rule", "Supporting & Related Material", "BKG-Background Material", "2010-04-30T04:00:00Z", 2010, 4, null, null, "2010-04-30T15:18:15Z", null, 0, 0, "0900006480ae387b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-D-0140-0009"], "units": {}, "query_ms": 0.4369488451629877, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}